Last CNY14.15 CNY
Change Today +0.13 / 0.93%
Volume 13.0M
As of 3:00 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

shanghai kaibao pharmaceut-a (300039) Snapshot

Open
CNY13.95
Previous Close
CNY14.02
Day High
CNY14.47
Day Low
CNY13.90
52 Week High
01/30/14 - CNY16.79
52 Week Low
12/11/13 - CNY11.18
Market Cap
8.9B
Average Volume 10 Days
9.7M
EPS TTM
CNY0.57
Shares Outstanding
631.3M
EX-Date
04/2/14
P/E TM
24.7x
Dividend
CNY0.22
Dividend Yield
1.53%
Current Stock Chart for SHANGHAI KAIBAO PHARMACEUT-A (300039)

Related News

No related news articles were found.

shanghai kaibao pharmaceut-a (300039) Related Businessweek News

No Related Businessweek News Found

shanghai kaibao pharmaceut-a (300039) Details

Shanghai Kaibao Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of Chinese medicines in China. The company offers clear away heat and toxic material injections, which are applied in the treatment of upper respiratory tract infections, such as cold and pneumonia; and doxofylline capsules for use in the treatment of bronchial asthma, as well as breathing difficulties caused by chronic asthmatic bronchitis and bronchial spasm. It also provides pioglitazone hydrochloride tablets for the treatment of diabetes; and captopril sustained-release tablets for treating high blood pressure and heart failure. Shanghai Kaibao Pharmaceutical Co., Ltd. was founded in 2000 and is based in Shanghai, China.

Founded in 2000

shanghai kaibao pharmaceut-a (300039) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shanghai kaibao pharmaceut-a (300039) Key Developments

Shanghai Kaibao Pharmaceutical Co., Ltd. to Report Q1, 2014 Results on Apr 09, 2014

Shanghai Kaibao Pharmaceutical Co., Ltd. announced that they will report Q1, 2014 results on Apr 09, 2014

Shanghai Kaibao Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2013

Shanghai Kaibao Pharmaceutical Co., Ltd. at its AGM of 2013, held on March 20, 2014, approved a tax included final cash dividend of CNY 2.6 per 10 shares under its 2013 profit distribution plan.

Shanghai Kaibao Pharmaceutical Co., Ltd., Annual General Meeting, Mar 20, 2014

Shanghai Kaibao Pharmaceutical Co., Ltd., Annual General Meeting, Mar 20, 2014., at 09:30 China Standard Time. Agenda: To consider 2013 work report of the supervisory committee; to consider 2013 work report of the board of directors; to consider 2013 annual report and its summary; to consider 2013 annual audit report; to consider 2013 financial resolution report; to consider 2013 profit distribution plan; to consider adjustment to remuneration for directors and supervisors; and to consider reappointment of 2014 audit firm.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300039:CH CNY14.15 CNY +0.13

300039 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300039.
View Industry Companies
 

Industry Analysis

300039

Industry Average

Valuation 300039 Industry Range
Price/Earnings 27.1x
Price/Sales 6.6x
Price/Book 5.4x
Price/Cash Flow 27.0x
TEV/Sales 5.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI KAIBAO PHARMACEUT-A, please visit www.xykb.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.